Leveraging SEER data through machine learning to predict distant lymph node metastasis and prognosticate outcomes in hepatocellular carcinoma patients
Authors:
- 26 August 2024
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 26 (9) , e3732
Abstract
Objectives: This study aims to develop and validate machine learning–based diagnostic and prognostic models to predict the risk of distant lymph node metastases (DLNM) in patients with hepatocellular carcinoma (HCC) and to evaluate the prognosis for this cohort.Design: Utilizing a retrospective design, this investigation leverages data extracted from the Surveillance, Epidemiology, and End Results (SEER) database, specifically the January 2024 subset, to conduct the analysis.Participants: The study cohort consists of 15,775 patients diagnosed with HCC as identified within the SEER database, spanning 2016 to 2020.Method: In the construction of the diagnostic model, recursive feature elimination (RFE) is employed for variable selection, incorporating five critical predictors: age, tumor size, radiation therapy, T‐stage, and serum alpha‐fetoprotein (AFP) levels. These variables are the foundation for a stacking ensemble model, which is further elucidated through Shapley Additive Explanations (SHAP). Conversely, the prognostic model is crafted utilizing stepwise backward regression to select pertinent variables, including chemotherapy, radiation therapy, tumor size, and age. This model culminates in the development of a prognostic nomogram, underpinned by the Cox proportional hazards model.Main outcome measures: The outcome of the diagnostic model is the occurrence of DLNM in patients. The outcome of the prognosis model is determined by survival time and survival status.Results: The integrated model developed based on stacking demonstrates good predictive performance and high interpretative variability and differentiation. The area under the curve (AUC) in the training set is 0.767, while the AUC in the validation set is 0.768. The nomogram, constructed using the Cox model, also demonstrates consistent and strong predictive capabilities. At the same time, we recognized elements that have a substantial impact on DLNM and the prognosis and extensively discussed their significance in the model and clinical practice.Conclusion: Our study identified key predictive factors for DLNM and elucidated significant prognostic indicators for HCC patients with DLNM. These findings provide clinicians with valuable tools to accurately identify high‐risk individuals for DLNM and conduct more precise risk stratification for this patient subgroup, potentially improving management strategies and patient outcomes.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFC2400603, 2022YFC2603501)
This publication has 26 references indexed in Scilit:
- Management of Hepatocellular CarcinomaJAMA Surgery, 2023
- Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After SurgeryJAMA Surgery, 2023
- Machine learning-enabled risk prediction of chronic obstructive pulmonary disease with unbalanced dataComputer Methods and Programs in Biomedicine, 2023
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateJournal of Hepatology, 2021
- Characteristics and risk differences of different tumor sizes on distant metastases of hepatocellular carcinoma: A retrospective cohort study in the SEER databaseInternational Journal of Surgery, 2020
- A serological scoring system to predict lymph node metastasis in patients with hepatocellular carcinomaHPB, 2019
- Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in KoreaCancer, 2018
- Emerging Biological Principles of MetastasisCell, 2017
- Significant impact of patient age on outcome after liver resection for HCC in cirrhosisEuropean Journal of Surgical Oncology, 2014
- Consideration of role of radiotherapy for lymph node metastases in patients with HCC: Retrospective analysis for prognostic factors from 125 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005